1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Otitis Externa Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Otitis Externa Clinical Trials by Region
2.2.2 Average Enrollment of Otitis Externa Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Otitis Externa Treatment, 2019

3. Region wise Otitis Externa Clinical Trials
3.1 Asia Pacific Otitis Externa Clinical Trials by Country
3.2 Europe Otitis Externa Clinical Trials by Country
3.3 North America Otitis Externa Clinical Trials by Country
3.4 Middle East and Africa Otitis Externa Clinical Trials by Country
3.5 South and Central America Otitis Externa Clinical Trials by Country

4. Otitis Externa Clinical Trial Trends
4.1 Start Year wise Otitis Externa Clinical Trials
4.2 Phase wise Otitis Externa Clinical Trials
4.3 Trial Status wise Otitis Externa Clinical Trials
4.4 Trial Type wise Otitis Externa Clinical Trials

5. Otitis Externa Average Enrollment Trends
5.1 Average Enrollment in Otitis Externa Trials by Year
5.2 Average Enrollment in Otitis Externa Trials by Phase
5.3 Average Enrollment in Otitis Externa Trials by Status
5.4 Average Enrollment in Otitis Externa Trials by Type of Trial

6. Companies Participating in Otitis Externa Clinical Trials
6.1 Otitis Externa Trials by Sponsor Type
6.2 Otitis Externa Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Otitis Externa Trials- Phase 1
7.2 Otitis Externa Trials- Phase 2
7.3 Otitis Externa Trials- Phase 3
7.4 Otitis Externa Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Otitis Externa Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Otitis Externa Clinical Trials and Enrolment
Figure 5: Europe – Country wise Otitis Externa Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Otitis Externa Clinical Trials and Enrolment
Figure 7: North America – Country wise Otitis Externa Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Otitis Externa Clinical Trials and Enrolment
Figure 9: Otitis Externa Clinical Trials by Phase
Figure 10: Otitis Externa Clinical Trials by Trial Status
Figure 11: Otitis Externa Clinical Trials by Type
Figure 12: Otitis Externa Clinical Trials by Sponsor Type
Figure 13: Otitis Externa Clinical Trials by Leading Sponsors
Figure 14: Otitis Externa Average Enrollment by Phase
Figure 15: Otitis Externa Average Enrollment by Trial Status
Figure 16: Otitis Externa Average Enrollment by Type
Figure 17: Otitis Externa- Average Enrolment by Type of Sponsors
Figure 18: Otitis Externa- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Otitis Externa Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Otitis Externa Clinical Trials and Enrolment
Table 5: Europe – Country wise Otitis Externa Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Otitis Externa Clinical Trials and Enrolment
Table 7: North America – Country wise Otitis Externa Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Otitis Externa Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Otitis Externa Average Enrollment by Phase
Table 15: Otitis Externa Average Enrollment by Trial Status
Table 16: Otitis Externa Average Enrollment by Type
Table 17: Otitis Externa- Average Enrolment by Type of Sponsors
Table 18: Otitis Externa- Enrolment by Leading Sponsors

Companies mentioned
AmpliPhi Biosciences Corp, bitop AG, Farmoquimica SA, Laboratorios SALVAT SA, MerLion Pharmaceuticals Pte Ltd, Novartis AG, Novum Pharmaceutical Research Services Inc, Otic Pharma Inc, Otonomy Inc, Shire Plc